You are at:
  • Home
  • Health
  • I Spent Weeks Comparing GLP-1 Programs and Most People Start Wrong

I Spent Weeks Comparing GLP-1 Programs and Most People Start Wrong

I Spent Weeks Comparing GLP-1 Programs and Most People Start Wrong

The mistake I see constantly: people spend hours reading about semaglutide vs. tirzepatide before they’ve even checked whether a program ships to their state or what the actual monthly bill looks like. Start with logistics and price. The drug debate comes second.

Here are nine programs I’d actually point someone to in 2026, ranked by how easy they are to get started, especially if you’re cash-paying and new to all of this.

1. HealthRX

Price is usually what stops people from even trying. HealthRX compounded semaglutide starts at $99/month and compounded tirzepatide at $149/month, which undercuts most telehealth competition by a real margin. Fill out the online health assessment, a board-certified US physician reviews it within roughly 24 hours, and medication ships overnight at no extra charge to all 50 states.

What I actually checked before listing it first: the dispensing pharmacy is Manifest Pharmacy in Greer, South Carolina, a 503A-compliant, USP-797 compounding pharmacy with lot tracking from bench to delivery. It carries LegitScript certification (cert 50087439). That’s a verifiable trail most budget options don’t offer.

Two numbers worth knowing: the SURMOUNT-1 trial reported roughly 21% average body weight reduction over 72 weeks with tirzepatide, and the STEP 1 trial showed about 15% over 68 weeks with semaglutide. HealthRX cites those figures. It does not claim its compounded versions are equivalent to the branded drugs, which is the right call legally and ethically.

Compounded medications are not FDA-approved. That’s a real caveat, not a footnote.

2. FormBlends

FormBlends sits just below HealthRX for one specific reason: the monthly cash price is higher (semaglutide around $299, tirzepatide around $349 per vial). But I’d tell a certain type of person to go here first.

FormBlends publishes per-product purity testing with actual numbers. HPLC purity, mass spectrometry identity confirmation, endotoxin and sterility results. Named figures, not vague assurances. For someone who wants documented batch-level quality data before injecting anything, that transparency is rare in this space.

READ ALSO  Why Preventive Dentistry Lowers Oral Health Costs Over Time

It also carries a broader peptide catalog, covering recovery, longevity, and cognitive support alongside GLP-1 options, all under the same physician-oversight model. Ships to 47 states. If you want GLP-1s and other peptides from one provider without juggling multiple telehealth accounts, this is the most logical pick.

3. Mochi Health

Mochi‘s clinical staff are physicians who hold board certification specifically in obesity medicine, not general practitioners filling in across specialties. That distinction matters for dosing conversations. Compounded semaglutide runs about $99/month, tirzepatide about $199/month. The monitoring is more hands-on than most budget programs. Good option if you want clinical depth without paying a premium program fee on top of medication costs.

4. Hims & Hers

After the March 2026 Novo Nordisk settlement, Hims & Hers moved away from compounded GLP-1s and shifted to branded medications. Injectable Wegovy is listed around $299/month, Zepbound around $399, and oral semaglutide around $249. With insurance and a savings card, some users report costs as low as $0 to $25. The app experience is polished. Best fit if you have insurance and want a big, well-supported platform.

5. PlushCare

PlushCare membership costs about $19.99/month. Branded medications billed separately. Same-day virtual visits are actually available, not just advertised. It takes insurance for branded GLP-1 scripts and handles prior authorization. For someone already comfortable with telehealth and wanting fast appointment access, this is efficient.

6. Ro Body

First month around $39, then $74 to $149/month for the program, with medications billed on top. Ro has a dedicated prior-authorization team that works with insurance on branded medications. The process is more involved than cash-pay programs, but the insurance support is legitimate and worth it for people with coverage.

7. Henry Meds

Cash-pay compounded program, no insurance required. First month typically $179 to $249. Shipping runs 24 to 72 hours. The monitoring is lighter than Mochi or Calibrate, which some people prefer and others find unsatisfying. Simple, fast, affordable.

READ ALSO  Why Cosmetic Dentistry Improves More Than Just Your Smile

8. Found

About $99/month for the platform, medications billed separately. Includes behavioral coaching alongside prescription access. More structure than a prescription-only service. Reasonable middle ground if you want some accountability without a full 12-month coaching commitment.

9. Eden

Compounded semaglutide around $149/month cash-pay. Straightforward intake process. No complicated add-ons. Eden is a solid starting point for someone who just wants the medication and a simple path to getting it prescribed without extra program fees layered on.

A Honest Note Before You Pick One

None of the compounded options on this list are FDA-approved drugs. Telehealth prescribing varies by state, pricing changes frequently, and more than 30 telehealth or compounding companies received FDA warning letters in early 2026. Check each company’s current status before you pay anything. This list reflects publicly available information as of mid-2026 and is not medical advice.

Common Questions

Which of these programs can you actually get started with the same day you apply?

HealthRX and Eden come closest. HealthRX promises physician review within roughly 24 hours and overnight shipping, while Eden’s intake is similarly lean. PlushCare offers same-day virtual visits, which is fast for a branded-medication path. Programs requiring prior authorization, like Ro or PlushCare for insurance billing, take longer because insurance timelines are outside any company’s control.

Does it matter which compounding pharmacy a GLP-1 program uses, or is one basically the same as another?

It matters more than most people realize. A 503A pharmacy like Manifest Pharmacy, which HealthRX uses, operates under state board oversight and must meet USP-797 sterility standards. FormBlends goes further by publishing HPLC purity figures and mass spectrometry results per batch. Vague claims about “quality compounding” with no named pharmacy or test data are a red flag worth taking seriously.

READ ALSO  What to Check Before Choosing Around Semaglutide Results By Month in 2026

If Hims & Hers stopped offering compounded GLP-1s after the March 2026 settlement, what does that mean for people who were already on their program?

The settlement shifted Hims & Hers toward branded options like Wegovy and Zepbound. Existing patients on compounded versions would have needed to transition. Branded medications carry a different cost structure, generally higher without insurance, though savings cards can reduce out-of-pocket costs significantly. Anyone mid-program should confirm their current prescription status directly with Hims & Hers.

Is the $99/month price at HealthRX and Mochi actually all-in, or are there fees that show up later?

For HealthRX, the published $99/month for compounded semaglutide includes overnight shipping, which is a real differentiator since some programs charge separately for delivery. Mochi’s $99 figure is for the medication itself, but the monitoring visits and clinical access are part of the program rather than billed as add-ons. Pricing changes, so confirm the current breakdown before completing intake on either platform.

For someone in a state where a program doesn’t ship, what’s the most practical fallback from this list?

HealthRX ships to all 50 states, making it the default fallback for state-restriction problems. FormBlends covers 47 states, so three states are excluded. Hims & Hers, PlushCare, and Ro operate on branded medications prescribed and filled through standard pharmacy networks, which generally sidesteps the state-shipping issue that compounders face. Check current availability directly, since telehealth licensing maps shift throughout the year.

Sources

  • FDA SURMOUNT-1 tirzepatide trial data (NEJM, 2022)
  • STEP 1 semaglutide trial (NEJM, 2021)
  • FDA 503A compounding pharmacy framework, FDA.gov
  • LegitScript pharmacy certification database
  • Novo Nordisk settlement announcement, March 9, 2026 (Reuters / Novo Nordisk press release)
  • Individual brand pricing pages (Hims & Hers, Ro, Mochi Health, PlushCare, Henry Meds, Found, Eden), verified Q2 2026

Leave a Comment

Your email address will not be published. Required fields are marked *